Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Wellnex Life.
RELATED STOCKHEAD STORIES
Experts
Free Whelan: Boeing, Boeing… gone?
Health & Biotech
Weed Week: Cannabis can ‘kill melanoma’; and Germany legalises weed possession
News
Market Highlights: Sigh of relief on inflation data, pig-butchering on the rise, and 5 ASX small caps to watch
Health & Biotech
Weed Week: Iron Mike throws down challenge to Biden, and recent ASX pot winners
Health & Biotech
Weed Week: Hey stoners, exercise is even better on weed; and recent ASX pot winners
Health & Biotech
Healthy balance sheet with no debt, this overlooked ASX health stock has been paying dividends for years
Experts
FREE WHELAN: What happened if you kept the faith in 2023
Experts
FREE WHELAN: The price of the US 10-year controls the world and it’s already on holiday
Health & Biotech
Wellnex Life to rise 117pc in next 12 months forecasts Vested Equities
Experts
FREE WHELAN: Life, death, turkey and power
News
Deals Within Reach: From critical minerals to healthcare and everything in between
Health & Biotech
Wellnex to get Pain Away for lower upfront cost en route to London Listing
Health & Biotech
Wellnex expands supply agreement with Haleon to sell paracetamol products in UK, Ireland and UAE
Health & Biotech
Wellnex to buy leading Australian pain relief brand Pain Away for $22 million
News
Closing Bell: It’s a win for the ASX, loss for the newly unemployed as Aussie jobless rate rises
News
ASX Quarterly Wrap: Growing pipeline, milestones, and bullish guidance were the themes for these stocks
Health & Biotech